false
--12-31
Q2
2026-06-30
2026
0001992818
0001992818
2026-01-01
2026-06-30
0001992818
2026-06-30
0001992818
2025-12-31
0001992818
2025-01-01
2025-06-30
0001992818
us-gaap:CommonStockMember
2025-12-31
0001992818
us-gaap:TreasuryStockCommonMember
2025-12-31
0001992818
us-gaap:AdditionalPaidInCapitalMember
2025-12-31
0001992818
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-12-31
0001992818
us-gaap:RetainedEarningsMember
2025-12-31
0001992818
ZOOZ:TreasuryStockMember
2025-12-31
0001992818
us-gaap:CommonStockMember
2024-12-31
0001992818
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0001992818
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0001992818
us-gaap:RetainedEarningsMember
2024-12-31
0001992818
2024-12-31
0001992818
us-gaap:CommonStockMember
2026-01-01
2026-06-30
0001992818
us-gaap:TreasuryStockCommonMember
2026-01-01
2026-06-30
0001992818
us-gaap:AdditionalPaidInCapitalMember
2026-01-01
2026-06-30
0001992818
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-01-01
2026-06-30
0001992818
us-gaap:RetainedEarningsMember
2026-01-01
2026-06-30
0001992818
ZOOZ:TreasuryStockMember
2026-01-01
2026-06-30
0001992818
us-gaap:CommonStockMember
2025-01-01
2025-06-30
0001992818
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-06-30
0001992818
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-01-01
2025-06-30
0001992818
us-gaap:RetainedEarningsMember
2025-01-01
2025-06-30
0001992818
us-gaap:CommonStockMember
2026-06-30
0001992818
us-gaap:TreasuryStockCommonMember
2026-06-30
0001992818
us-gaap:AdditionalPaidInCapitalMember
2026-06-30
0001992818
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-06-30
0001992818
us-gaap:RetainedEarningsMember
2026-06-30
0001992818
ZOOZ:TreasuryStockMember
2026-06-30
0001992818
us-gaap:CommonStockMember
2025-06-30
0001992818
us-gaap:AdditionalPaidInCapitalMember
2025-06-30
0001992818
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-06-30
0001992818
us-gaap:RetainedEarningsMember
2025-06-30
0001992818
2025-06-30
0001992818
us-gaap:InvestorMember
2026-01-01
2026-06-30
0001992818
2026-02-12
2026-02-12
0001992818
ZOOZ:BIRDFoundationMember
2025-01-01
2025-06-30
0001992818
ZOOZ:BIRDFoundationMember
2026-01-01
2026-06-30
0001992818
ZOOZ:BIRDFoundationMember
2026-06-30
0001992818
2025-11-01
2025-11-30
0001992818
2026-05-11
2026-05-11
0001992818
ZOOZ:EquityClassifiedAwardsMember
2026-01-01
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
srt:MinimumMember
2026-01-01
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
srt:MaximumMember
2026-01-01
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
srt:MinimumMember
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
srt:MaximumMember
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
2025-12-31
0001992818
ZOOZ:EquityClassifiedAwardsMember
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceOneMember
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceOneMember
2026-01-01
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceTwoMember
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceTwoMember
2026-01-01
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceThreeMember
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceThreeMember
2026-01-01
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceFourMember
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceFourMember
2026-01-01
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceFiveMember
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceFiveMember
2026-01-01
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceSixMember
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceSixMember
2026-01-01
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceSevenMember
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceSevenMember
2026-01-01
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceEightMember
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceEightMember
2026-01-01
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceNineMember
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceNineMember
2026-01-01
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceTenMember
2026-06-30
0001992818
ZOOZ:EquityClassifiedAwardsMember
ZOOZ:ExercisePriceTenMember
2026-01-01
2026-06-30
0001992818
us-gaap:RestrictedStockUnitsRSUMember
2025-09-01
2025-09-30
0001992818
us-gaap:RestrictedStockUnitsRSUMember
srt:OfficerMember
2025-09-01
2025-09-30
0001992818
us-gaap:RestrictedStockUnitsRSUMember
ZOOZ:TwoDirectorsMember
2025-10-01
2025-10-31
0001992818
us-gaap:RestrictedStockUnitsRSUMember
srt:OfficerMember
2025-11-01
2025-11-30
0001992818
us-gaap:RestrictedStockUnitsRSUMember
ZOOZ:FourDirectorsMember
2025-11-01
2025-11-30
0001992818
us-gaap:RestrictedStockUnitsRSUMember
2026-04-01
2026-04-30
0001992818
us-gaap:RestrictedStockUnitsRSUMember
2026-01-01
2026-06-30
0001992818
us-gaap:RestrictedStockUnitsRSUMember
2025-12-31
0001992818
us-gaap:RestrictedStockUnitsRSUMember
2026-06-30
0001992818
us-gaap:CostOfSalesMember
ZOOZ:EquityClassifiedAwardsMember
2026-01-01
2026-06-30
0001992818
us-gaap:CostOfSalesMember
ZOOZ:EquityClassifiedAwardsMember
2025-01-01
2025-06-30
0001992818
us-gaap:ResearchAndDevelopmentExpense
ZOOZ:EquityClassifiedAwardsMember
2026-01-01
2026-06-30
0001992818
us-gaap:ResearchAndDevelopmentExpense
ZOOZ:EquityClassifiedAwardsMember
2025-01-01
2025-06-30
0001992818
us-gaap:SellingAndMarketingExpense
ZOOZ:EquityClassifiedAwardsMember
2026-01-01
2026-06-30
0001992818
us-gaap:SellingAndMarketingExpense
ZOOZ:EquityClassifiedAwardsMember
2025-01-01
2025-06-30
0001992818
us-gaap:GeneralAndAdministrativeExpense
ZOOZ:EquityClassifiedAwardsMember
2026-01-01
2026-06-30
0001992818
us-gaap:GeneralAndAdministrativeExpense
ZOOZ:EquityClassifiedAwardsMember
2025-01-01
2025-06-30
0001992818
us-gaap:RelatedPartyMember
2026-01-01
2026-06-30
0001992818
us-gaap:RelatedPartyMember
2025-01-01
2025-06-30
0001992818
us-gaap:RelatedPartyMember
us-gaap:ResearchAndDevelopmentExpense
2026-01-01
2026-06-30
0001992818
us-gaap:RelatedPartyMember
us-gaap:ResearchAndDevelopmentExpense
2025-01-01
2025-06-30
0001992818
us-gaap:RelatedPartyMember
us-gaap:GeneralAndAdministrativeExpense
2026-01-01
2026-06-30
0001992818
us-gaap:RelatedPartyMember
us-gaap:GeneralAndAdministrativeExpense
2025-01-01
2025-06-30
0001992818
us-gaap:RestrictedStockUnitsRSUMember
srt:ChiefExecutiveOfficerMember
2025-01-01
2025-12-31
0001992818
us-gaap:RestrictedStockUnitsRSUMember
2025-01-01
2025-12-31
0001992818
2025-01-01
2025-12-31
0001992818
ZOOZ:FlywheelMember
2026-01-01
2026-06-30
0001992818
us-gaap:CorporateAndOtherMember
2026-01-01
2026-06-30
0001992818
ZOOZ:FlywheelMember
2026-06-30
0001992818
us-gaap:CorporateAndOtherMember
2026-06-30
0001992818
ZOOZ:FlywheelMember
2025-01-01
2025-06-30
0001992818
us-gaap:CorporateAndOtherMember
2025-01-01
2025-06-30
0001992818
ZOOZ:FlywheelMember
2025-06-30
0001992818
us-gaap:CorporateAndOtherMember
2025-06-30
0001992818
ZOOZ:UnvestedMember
2026-01-01
2026-06-30
0001992818
us-gaap:EmployeeStockOptionMember
2026-01-01
2026-06-30
0001992818
us-gaap:WarrantMember
2026-01-01
2026-06-30
0001992818
ZOOZ:EarnoutSharesRightsMember
2026-01-01
2026-06-30
0001992818
us-gaap:EmployeeStockOptionMember
2025-01-01
2025-06-30
0001992818
us-gaap:WarrantMember
2025-01-01
2025-06-30
0001992818
ZOOZ:EarnoutSharesRightsMember
2025-01-01
2025-06-30
0001992818
us-gaap:SubsequentEventMember
2026-08-23
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
iso4217:ILS
xbrli:shares
iso4217:ILS
ZOOZ:Integer
Exhibit
99.1
ZOOZ
STRATEGY LTD
CONDENSED
CONSOLIDATED INTERIM FINANCIAL STATEMENTS
(UNAUDITED)
AS
OF JUNE 30, 2026
ZOOZ
STRATEGY LTD
CONDENSED
INTERIM FINANCIAL STATEMENTS (UNAUDITED)
AS
OF JUNE 30, 2026
TABLE
OF CONTENTS
| |
Page |
| |
|
| UNAUDITED
CONDENSED FINANCIAL STATEMENTS: |
|
| Condensed Consolidated Balance sheets |
2 |
| Condensed Consolidated Statements of Operations |
3 |
| Condensed Consolidated Statements of Comprehensive loss |
4 |
| Condensed Consolidated Statements of changes in shareholders’ equity |
5-6 |
| Condensed Consolidated Statements of cash flows |
7 |
| Notes to the Condensed Consolidated financial statements |
8-16 |
ZOOZ
STRATEGY LTD
CONDENSED
CONSOLIDATED BALANCE SHEETS
(Unaudited)
| | |
June
30 | | |
December
31 | |
| | |
2026 | | |
2025 | |
| | |
U.S.
dollars in thousands | |
| Assets | |
| | |
| |
| CURRENT ASSETS: | |
| | | |
| | |
| Cash and cash
equivalents | |
| 23,271 | | |
| 27,028 | |
| Short term deposits | |
| 42 | | |
| 39 | |
| Prepaid expenses | |
| 570 | | |
| 571 | |
| Other
current assets | |
| 647 | | |
| 1,264 | |
| TOTAL
CURRENT ASSETS | |
| 24,530 | | |
| 28,902 | |
| | |
| | | |
| | |
| NON-CURRENT ASSETS: | |
| | | |
| | |
| Restricted bank deposits | |
| 236 | | |
| 221 | |
| Prepaid expenses | |
| 568 | | |
| 799 | |
| Digital assets | |
| 61,300 | | |
| 91,628 | |
| Operating lease right of
use assets | |
| 581 | | |
| 726 | |
| Property
and equipment, net | |
| 213 | | |
| 289 | |
| TOTAL
NON-CURRENT ASSETS | |
| 62,898 | | |
| 93,663 | |
| TOTAL
ASSETS | |
| 87,428 | | |
| 122,565 | |
| | |
| | | |
| | |
| Liabilities and equity | |
| | | |
| | |
| CURRENT LIABILITIES: | |
| | | |
| | |
| Accounts payable | |
| 64 | | |
| 178 | |
| Other payables and accrued
expenses | |
| 1,181 | | |
| 2,161 | |
| Short-term employee benefits | |
| 323 | | |
| 302 | |
| Current
maturities of operating lease liabilities | |
| 329 | | |
| 292 | |
| TOTAL
CURRENT LIABILITIES | |
| 1,897 | | |
| 2,933 | |
| | |
| | | |
| | |
| NON-CURRENT LIABILITIES: | |
| | | |
| | |
| Operating
lease liabilities | |
| 293 | | |
| 432 | |
| TOTAL
NON-CURRENT LIABILITIES | |
| 293 | | |
| 432 | |
| | |
| | | |
| | |
| TOTAL
LIABILITIES | |
| 2,190 | | |
| 3,365 | |
| | |
| | | |
| | |
| COMMITMENTS AND CONTINGENCIES
(Note 6) | |
| - | | |
| - | |
| | |
| | | |
| | |
| SHAREHOLDERS’ EQUITY: | |
| | | |
| | |
| Share capital - Ordinary shares of NIS 0.0572
par value - Authorized: 50,000,000 shares on June 30, 2026, and December 31, 2025; Issued: 8,101,159 shares on June 30, 2026, and
8,099,799 on December 31, 2025; Outstanding: 8,009,608 shares on June 30, 2026, and 8,099,799 on December 31, 2025; | |
| 139 | | |
| 139 | |
| Treasury stock at cost,
91,551 shares at June 30, 2026 | |
| (881 | ) | |
| - | |
| Additional paid-in capital | |
| 247,857 | | |
| 234,083 | |
| Accumulated other comprehensive
loss | |
| (1,262 | ) | |
| (1,262 | ) |
| Accumulated
deficit | |
| (160,615 | ) | |
| (113,760 | ) |
| TOTAL
EQUITY | |
| 85,238 | | |
| 119,200 | |
| TOTAL
LIABILITIES AND EQUITY | |
| 87,428 | | |
| 122,565 | |
*
All share and per share information retroactively reflects reverse stock split – see note 1.
The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
ZOOZ
STRATEGY LTD
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(U.S.
dollars in thousands, except share and per share data)
(Unaudited)
| | |
2026 | | |
2025 | |
| | |
Six months ended June
30, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Revenues | |
| - | | |
| 247 | |
| Cost of revenue | |
| - | | |
| 1,792 | |
| | |
| | | |
| | |
| Gross loss | |
| - | | |
| (1,545 | ) |
| | |
| | | |
| | |
| Research and development, net | |
| 896 | | |
| 2,352 | |
| Sales and marketing | |
| 45 | | |
| 998 | |
| General and administrative | |
| 15,612 | | |
| 1,950 | |
| Unrealized loss on digital
assets | |
| 30,328 | | |
| - | |
| | |
| | | |
| | |
| Operating loss | |
| (46,881 | ) | |
| (6,845 | ) |
| | |
| | | |
| | |
| Finance
income (expenses), net | |
| 26 | | |
| (200 | ) |
| Net
loss | |
| (46,855 | ) | |
| (7,045 | ) |
| | |
| | | |
| | |
| Net loss per ordinary
share attributable to shareholders - basic and diluted | |
| (4.93 | ) | |
| (12.2 | ) |
| Weighted average ordinary
shares outstanding – basic and diluted | |
| 9,498 | | |
| 577 | |
*
All share and per share information retroactively reflects reverse stock split – see note 1.
The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
ZOOZ
STRATEGY LTD
CONDENSED
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(Unaudited)
| | |
2026 | | |
2025 | |
| | |
Six
months ended June 30, | |
| | |
2026 | | |
2025 | |
| | |
U.S.
dollars in
thousands | |
| Net Loss | |
| (46,855 | ) | |
| (7,045 | ) |
| | |
| | | |
| | |
| Other Comprehensive gain (loss) | |
| | | |
| | |
| Reporting
currency translation gain (loss) | |
| - | | |
| 88 | |
| | |
| | | |
| | |
| Total other comprehensive gain (loss) | |
| - | | |
| 88 | |
| | |
| | | |
| | |
| Total
comprehensive loss | |
| (46,855 | ) | |
| (6,957 | ) |
The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
ZOOZ
STRATEGY LTD
CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(U.S.
dollars in thousands, except share and per share data)
(Unaudited)
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| | |
Share
capital | | |
Treasury
stock | | |
Additional | | |
Accumulated
other | | |
| | |
| |
| | |
Number
of Shares | | |
Amount | | |
Number
of
Shares | | |
Amount | | |
paid-in
capital | | |
comprehensive
loss | | |
Accumulated
loss | | |
Total | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| BALANCE AS
OF JANUARY 1, 2026 | |
| 8,099,799 | | |
| 139 | | |
| - | | |
| - | | |
| 234,083 | | |
| (1,262 | ) | |
| (113,760 | ) | |
| 119,200 | |
| CHANGES IN 2026: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Repurchase of Ordinary Shares | |
| - | | |
| - | | |
| (91,551 | ) | |
| (881 | ) | |
| - | | |
| - | | |
| - | | |
| (881 | ) |
| Exercise of vested RSUs | |
| 1,360 | | |
| -(*) | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| -(*) | |
| Share-based compensation | |
| - | | |
| - | | |
| - | | |
| - | | |
| 13,774 | | |
| - | | |
| - | | |
| 13,774 | |
| Net
loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (46,855 | ) | |
| (46,855 | ) |
| BALANCE AS OF JUNE 30,
2026 | |
| 8,101,159 | | |
| 139 | | |
| (91,551 | ) | |
| (881 | ) | |
| 247,857 | | |
| (1,262 | ) | |
| (160,615 | ) | |
| 85,238 | |
*
All share and per share information retroactively reflects reverse stock split – see note 1.
The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
ZOOZ
STRATEGY LTD
CONDENSED
CONSOLIDATED STATEMENTS OF AND CHANGES IN SHAREHOLDERS’ EQUITY
(U.S.
dollars in thousands, except share and per share data)
(Unaudited)
| | |
Shares | | |
Amount | | |
capital | | |
loss | | |
loss | | |
Total | |
| | |
Share
capital | | |
| | |
Accumulated | | |
| | |
| |
| | |
Number
of Shares | | |
Amount | | |
Additional
paid-in capital | | |
other
comprehensive income (loss) | | |
Accumulated
loss | | |
Total | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| BALANCE AS
OF JANUARY 1, 2025 | |
| 605,275 | | |
| 10 | | |
| 67,026 | | |
| (2,147 | ) | |
| (58,171 | ) | |
| 6,718 | |
| Balance | |
| 605,275 | | |
| 10 | | |
| 67,026 | | |
| (2,147 | ) | |
| (58,171 | ) | |
| 6,718 | |
| CHANGES IN 2025: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Issuance of shares according
to the SEPA | |
| 1,975 | | |
| -(*) | | |
| 34 | | |
| - | | |
| - | | |
| 34 | |
| Share-based compensation | |
| | | |
| | | |
| 59 | | |
| - | | |
| - | | |
| 59 | |
| Net loss | |
| | | |
| | | |
| | | |
| | | |
| (7,045 | ) | |
| (7,045 | ) |
| Other comprehensive gain | |
| | | |
| | | |
| | | |
| 88 | | |
| | | |
| 88 | |
| BALANCE AS OF JUNE 30, 2025 | |
| 607,250 | | |
| 10 | | |
| 67,119 | | |
| (2,059 | ) | |
| (65,216 | ) | |
| (146 | ) |
| Balance | |
| 607,250 | | |
| 10 | | |
| 67,119 | | |
| (2,059 | ) | |
| (65,216 | ) | |
| (146 | ) |
*
All share and per share information retroactively reflects reverse stock split – see note 1.
The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
ZOOZ
STRATEGY LTD
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| | |
2026 | | |
2025 | |
| | |
Six
months ended June 30 | |
| | |
2026 | | |
2025 | |
| | |
U.S.
dollars in thousands | |
| CASH FLOWS FROM OPERATING
ACTIVITIES: | |
| | | |
| | |
| Net loss | |
| (46,855 | ) | |
| (7,045 | ) |
| Adjustments to reconcile
net loss to net cash used in operating activities: | |
| | | |
| | |
| Depreciation and amortization | |
| 76 | | |
| 151 | |
| Unrealized loss on digital
assets | |
| 30,328 | | |
| - | |
| Non-cash finance expenses,
net | |
| 16 | | |
| 247 | |
| Net changes in operating
lease assets and liabilities | |
| 43 | | |
| 31 | |
| Share-based compensation | |
| 13,774 | | |
| 59 | |
| Changes in operating assets
and liabilities: | |
| | | |
| | |
| Prepaid expenses and other
current assets | |
| 849 | | |
| 64 | |
| Inventory | |
| - | | |
| 1,240 | |
| Accounts payable | |
| (114 | ) | |
| 253 | |
| Other payables and accrued
expenses | |
| (980 | ) | |
| 11 | |
| Short-term
employee benefits | |
| 21 | | |
| 39 | |
| | |
| | | |
| | |
| Net
cash used in operating activities | |
| (2,842 | ) | |
| (4,950 | ) |
| | |
| | | |
| | |
| CASH FLOWS FROM INVESTING
ACTIVITIES: | |
| | | |
| | |
| Purchase of equipment | |
| - | | |
| (91 | ) |
| | |
| | | |
| | |
| Net
cash used in investing activities | |
| - | | |
| (91 | ) |
| | |
| | | |
| | |
| CASH FLOWS FROM FINANCING
ACTIVITIES: | |
| | | |
| | |
| Proceeds from issuance
of shares, net of issuance costs | |
| - | | |
| 34 | |
| Repurchase of Ordinary
Shares | |
| (881 | ) | |
| - | |
| | |
| | | |
| | |
| Net
cash provided by (used in) financing activities | |
| (881 | ) | |
| 34 | |
| | |
| | | |
| | |
| Effect of change in exchange on cash balances
in foreign currencies | |
| (16 | ) | |
| (54 | ) |
| Net change in cash and cash equivalent | |
| (3,739 | ) | |
| (5,061 | ) |
| Cash and cash equivalents
and restricted bank deposits at beginning of year | |
| 27,288 | | |
| 7,758 | |
| Cash and cash equivalents
and restricted bank deposits at end of year | |
| 23,549 | | |
| 2,697 | |
The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
ZOOZ
STRATEGY LTD
NOTES
TO THE FINANCIAL STATEMENTS (continued)
(Unaudited)
NOTE
1 - GENERAL:
ZOOZ
Strategy Ltd. (formerly – ZOOZ Power) (hereinafter - “the Company”), an Israeli Company, was incorporated and commenced
operations in Israel on February 5, 2013. The offices of the Company are located at 4 Hamelacha St., Lod, Israel.
The
Company operates as one operating segment focused on developing and marketing Flywheel-based power boosting and power management solutions.
The system is based on kinetic storage using flywheels.
In
July 2025 the Company adopted bitcoin as its primary treasury reserve asset on an ongoing basis. The Company continues to maintain its
flywheel technology and related activities; however, the scale of such activities has decreased compared to prior periods.
On
October 16, 2025, the Company changed its name from ZOOZ Power to ZOOZ Strategy.
On
July 29, 2025, the Company entered into securities purchase agreements with certain institutional and accredited investors for a private
placement consisting of ordinary shares, pre-funded warrants, and warrants (the “Private Placement”).
Cash
proceeds received from investors totaled approximately $167 million, resulting in net proceeds of approximately $153 million.
During
the period between January 5, 2026, and February 12, 2026, the Company repurchased 91,551 of its ordinary shares pursuant to a Rule 10b5-1
Repurchase Plan. For further details see note 7.
On
May 11, 2026, the extraordinary general meeting of the Company’s shareholders approved a reverse share split of the Company’s
ordinary Shares, effective as of June 1, 2026, at a conversion ratio of 20. For further details see note 7.
Operations
in Israel
In
October 2023, following terrorist attacks in southern Israel, the Israeli government declared war against Hamas and commenced a military
campaign in the Gaza Strip (the “Swords of Iron” war). Since then, there have been additional hostilities along Israel’s
borders and regional security escalations, including military actions involving Iran and related operations such as “Operation
Rising Lion.” To date, the Company’s operations and financial results have not been materially affected by these events.
However, as these developments are beyond the Company’s control, their continuation or escalation could adversely affect the Company’s
operations in the future.
Liquidity
The
Company incurred net losses for the six months ended June 30, 2026, and June 30, 2025, in the amounts of $46,855 thousand and $7,045
thousand and generated negative cash flows from operating activities of $2,842 thousand and $4,950 thousand, respectively. The Company’s
cash balance as of June 30, 2026, is $23,271 thousand.
The
Company has historically financed its operations primarily through capital raising transactions. During 2025, the Company completed equity
capital raising transactions, including private placements and at-the-market offerings, resulting in net proceeds of approximately $153
million.
The
Company generated limited revenues from its ongoing operations in prior periods. In addition, during 2025 the Company adopted a treasury
strategy pursuant to which a substantial portion of the funds raised was invested in bitcoin.
While
the Company’s digital asset holdings are subject to market volatility and do not generate operating cash flows, management believes
that the Company’s existing cash balances, together with its ability, if necessary, to utilize its liquid resources, including
digital asset holdings to finance its operating expenditures, will be sufficient to meet its anticipated operating and capital requirements
for at least the twelve months following the date of issuance of these financial statements.
ZOOZ
STRATEGY LTD
NOTES
TO THE FINANCIAL STATEMENTS (continued)
(Unaudited)
NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES:
Use
of estimates
The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
amounts reported in the financial statements and accompanying notes. ZOOZ’s management believes that the estimates, judgments,
and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions
can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial
statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates,
and such differences may have a material impact on the Company’s financial statements.
Basis
of presentation of financial statements
The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (“US GAAP”) and applicable rules and regulations of the Securities and Exchange Commission
(“SEC”) for interim financial reporting.
Certain
information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed
or omitted pursuant to such rules and regulations. In the opinion of management, the information contained herein reflects all adjustments
necessary for a fair statement of our results of operations, financial position, cash flows, and shareholders’ equity. All such
adjustments are of a normal, recurring nature.
The
results of operations for the six months ended June 30, 2026, shown in these financial statements are not necessarily indicative of the
results to be expected for the full year ending December 31, 2026. The unaudited condensed financial statements should be read in conjunction
with the audited financial statements for the year ended December 31, 2025, included in the Company’s Annual Report on Form 20-F
filed with the SEC on March 27, 2026.
There
have been no material changes in our significant accounting policies as described in our financial statements for the year ended December
31, 2025.
The
carrying value of cash and cash equivalents, other current assets and accounts payables, other payables and accrued expenses (included
in the condensed balance sheets) approximates their fair value because of their generally short maturities. The promissory notes bear
annual interest at rates close to the prevailing market rates.
The
fair value of restricted bank deposits approximates the carrying value since they bear interest at rates close to the prevailing market
rates.
Treasury
shares
Treasury
shares are presented as a reduction of shareholders’ equity, at their cost to the Company. The Treasury shares are not entitled
to any rights, such as voting rights and distributions. The Treasury shares were purchased in the open market
ZOOZ
STRATEGY LTD
NOTES
TO THE FINANCIAL STATEMENTS (continued)
(Unaudited)
Concentration
of credit risks
Financial
instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, restricted bank
deposits, other receivables and digital assets.
The
Company’s cash and cash equivalents and restricted short and long-term bank deposits are invested in banks in Israel. Accordingly,
management believes that these restricted bank deposits have minimal credit risk.
New
Accounting Pronouncements:
Accounting
Pronouncements effective in future periods
In
December 2023, the FASB issued ASU 2023-09 Improvements to Income Tax Disclosures. The ASU improves the transparency of income tax disclosures
by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid
disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. The
ASU is effective for the Company for annual periods beginning after December 15, 2025. The Company is evaluating the potential impact
of this guidance on its consolidated financial statements. The amendments in this Update should be applied on a prospective basis.
In
2025, the FASB issued guidance, ASU 2024-03, which requires the disaggregated disclosure of certain costs and expenses on an interim
and annual basis. The new standard is effective for annual periods beginning after December 15, 2026, and interim periods beginning after
December 15, 2027, and can be applied prospectively with the option for retrospective application to all prior periods presented in the
financial statements. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial
statements and related disclosures.
Note
3 – DIGITAL ASSETS:
The
vast majority of the Company’s assets are concentrated in its bitcoin holdings. Bitcoin is a digital asset, which is a novel asset
class that is subject to significant legal, commercial, regulatory and technical uncertainty. Holding bitcoin does not generate any cash
flows and involves custodial fees and other costs. Additionally, the price of bitcoin has historically experienced significant price
volatility, and a significant decrease in the price of bitcoin would adversely affect the Company’s financial condition and results
of operations. The Company’s strategy of acquiring and holding bitcoin also exposes it to counterparty risks with respect to the
custody of its bitcoin, cybersecurity risks, and other risks inherent to holding a digital asset.
The
Company accounts for its digital assets, which are comprised solely of bitcoin, as indefinite-lived intangible assets in accordance
with ASC 350-60, Intangibles — Goodwill and Other – Crypto Assets. Company’s digital assets are initially recorded
at cost. Bitcoin assets are measured at fair value as of each reporting period based on Level 1 inputs in the fair value
hierarchy.
The
following table summarizes the Company’s digital asset holdings (in thousands, except number of bitcoins), as of:
SCHEDULE
OF DIGITAL ASSET HOLDINGS
| | |
| | |
| |
| | |
Six
months ended June 30 | |
| | |
2026 | | |
2025 | |
| Outstanding at beginning of year | |
| 91,628 | | |
| - | |
| Additions (purchases) | |
| - | | |
| - | |
| Disposals | |
| - | | |
| - | |
| Unrealized loss on digital
assets | |
| (30,328 | ) | |
| - | |
| Balance at end of period | |
| 61,300 | | |
| - | |
| Approximate number of
bitcoins held | |
| 1,047 | | |
| - | |
ZOOZ
STRATEGY LTD
NOTES
TO THE FINANCIAL STATEMENTS (continued)
(Unaudited)
The
following table summarizes the Company’s digital asset cost basis and unrealized loss on digital assets (in thousands) for the
periods indicated:
SCHEDULE
OF DIGITAL ASSET COST BASIS AND UNREALIZED LOSS ON DIGITAL ASSETS
| | |
As
of June 30, | |
| | |
2026 | | |
2025 | |
| Digital asset cost basis | |
| 121,935 | | |
| - | |
| Digital asset fair value | |
| 61,300 | | |
| - | |
NOTE
4 - CASH AND CASH EQUIVALENTS AND RESTRICTED BANK DEPOSITS:
The
following table provides a reconciliation of cash and cash equivalents and restricted bank deposits reported on the balance sheets that
sum to the same total amount as shown in the statements of cash flow:
SCHEDULE
OF RECONCILIATION OF CASH AND RESTRICTED DEPOSITS
| | |
June 30, | | |
December 31, | |
| | |
2026 | | |
2025 | |
| | |
U.S.
dollars in thousands | |
| | |
| | |
| |
| Cash and cash equivalents | |
| 23,271 | | |
| 27,028 | |
| Restricted bank deposits
(1) | |
| 278 | | |
| 260 | |
| Total cash and cash equivalents
and restricted bank deposits shown in the statement of cash flows | |
| 23,549 | | |
| 27,288 | |
NOTE
5 - OTHER PAYABLES AND ACCRUED EXPENSES:
SCHEDULE
OF OTHER PAYABLES AND ACCRUED EXPENSES
| | |
June 30, | | |
December 31, | |
| | |
2026 | | |
2025 | |
| | |
U.S.
dollars in thousands | |
| | |
| | |
| |
| Accrued expenses | |
| 751 | | |
| 989 | |
| Grants in advance | |
| 151 | | |
| 141 | |
| Escrow payables | |
| - | | |
| 773 | |
| Others | |
| 279 | | |
| 258 | |
| Other payables and accrued
expenses | |
| 1,181 | | |
| 2,161 | |
NOTE
6 - COMMITMENTS AND CONTINGENCIES:
The
total amount of grants received from the BIRD Foundation and from NYPA during the six-month period ended June 30, 2025, is $278 thousand.
An amount of $18 thousand was deducted from research and development expenses for the period ended on June 30, 2025. An amount of $180
thousand was deducted from Sales and Marketing expenses for the period ended June 30, 2025 (the amount deducted was received during 2023
and was recorded as liability as of December 31, 2023). Following the Company’s commitment to pay royalties to the IIA and to other
governmental institutions, and the sales incurred during the six months ended June 30, 2025, the Company recorded a provision of $20
thousand for royalties to the IIA and other governmental institutions. Total contingent obligation as of June 30, 2026, amounts to $2.5
million.
ZOOZ
STRATEGY LTD
NOTES
TO THE FINANCIAL STATEMENTS (continued)
(Unaudited)
NOTE
7 –EQUITY:
| (1) | On
November 2025 the Company initiated a share repurchase program (the – “Buyback”),
at an aggregate amount of up to $50 million. As of June 30, 2026, the Company has repurchased
a total of 91,551 shares at a total consideration of $0.9 million. |
| (2) | On
May 11, 2026, the extraordinary general meeting of the Company’s shareholders approved
a reverse share split of the Company’s ordinary Shares, effective as of June 1, 2026,
at a conversion ratio of 1 for 20. |
The
Company accounted for the Reverse Stock Splits on a retroactive basis pursuant to ASC 260. As a result, all common stock, warrants, and
options outstanding and exercisable for common stock, exercise prices and loss per share amounts have been adjusted, on a retroactive
basis, for all periods presented in these financial statements and the applicable disclosures, to reflect such Reverse Stock Split.
NOTE
8 - SHARE BASED COMPENSATION:
Equity
classified awards.
The
value of benefit is measured on the grant date by reference to the fair value of the granted equity instruments, as described below.
The fair value is calculated using the Black and Scholes formula, with the following assumptions:
SCHEDULE
OF FAIR VALUE ASSUMPTIONS
| | |
June 30, 2025 |
| Dividend yield | |
| 0 | % |
| Expected volatility | |
| 55%-89 | % |
| Risk-free interest rate | |
| 3.3%-5.8 | % |
| Expected term (years) | |
| 2-7 years | |
| Exercise price (USD) | |
| 39.60-389.60 | |
The
following is summary information of equity classified options in 2026:
SCHEDULE
OF STOCK OPTIONS ACTIVITY
| | |
Six
months ended June 30, 2026 | |
| | |
| | |
Weighted
average exercise price | | |
Weighted
average remaining contractual life | | |
Aggregate
Intrinsic | |
| | |
Number | | |
USD | | |
years | | |
Value | |
| Outstanding as of December 31, 2025 | |
| 27,538 | | |
| 145.40 | | |
| 5.86 | | |
| - | |
| Forfeited | |
| (6,343 | ) | |
| 60.02 | | |
| 7.17 | | |
| - | |
| Outstanding as of June 30, 2026 | |
| 21,195 | | |
| 176.13 | | |
| 4.83 | | |
| - | |
| Exercisable as of June 30, 2026 | |
| 20,905 | | |
| 176.37 | | |
| 4.81 | | |
| - | |
The
following is information regarding exercise prices and remaining contractual lives of outstanding options as of June 30, 2026:
SCHEDULE OF EXERCISE PRICES AND REMAINING CONTRACTUAL LIVES OF OUTSTANDING OPTIONS
| June
30, 2026 |
| outstanding | |
Exercisable | |
| Number
of options outstanding | |
Exercise
price range (USD) | | |
Weighted
average remaining contractual life | | |
Number
of options Exercisable | | |
Exercise
price range (USD) | | |
Weighted
average remaining contractual life | |
| 54 | |
| 106.77 | | |
| 6.68 | | |
| 54 | | |
| 106.77 | | |
| 6.68 | |
| 481 | |
| 116.85 | | |
| 6.48 | | |
| 418 | | |
| 116.85 | | |
| 6.48 | |
| 1,006 | |
| 144.87 | | |
| 6.02 | | |
| 943 | | |
| 144.87 | | |
| 6.02 | |
| 2,282 | |
| 151.43 | | |
| 1.52 | | |
| 2,282 | | |
| 151.43 | | |
| 1.52 | |
| 11,239 | |
| 156.34 | | |
| 4.33 | | |
| 11,239 | | |
| 156.34 | | |
| 4.33 | |
| 1,312 | |
| 179.74 | | |
| 6.34 | | |
| 1,148 | | |
| 179.74 | | |
| 6.34 | |
| 1,505 | |
| 192.03 | | |
| 6.80 | | |
| 1,505 | | |
| 192.03 | | |
| 6.80 | |
| 1,505 | |
| 220.45 | | |
| 6.80 | | |
| 1,505 | | |
| 220.45 | | |
| 6.80 | |
| 1,505 | |
| 286.51 | | |
| 6.80 | | |
| 1,505 | | |
| 286.51 | | |
| 6.80 | |
| 306 | |
| 441.05 | | |
| 5.34 | | |
| 306 | | |
| 441.05 | | |
| 5.34 | |
| 21,195 | |
| 176.13 | | |
| 4.83 | | |
| 20,905 | | |
| 176.37 | | |
| 4.81 | |
As
of June 30, 2026, there is an unrecognized share-based compensation expense of $3 thousand to be recognized over the average remaining
vesting period of 0.31 years.
ZOOZ
STRATEGY LTD
NOTES
TO THE FINANCIAL STATEMENTS (continued)
(Unaudited)
Restricted
Stock Units
In
September 2025, the Company granted 336,341 restricted stock units of the Company, to an officer who is a related party, with whom the
Company has no employment relationship. The RSUs will vest over 4 years from the date of the grant - 25% each year.
In
September 2025, the Company granted 672,682 restricted stock units of the Company to an officer who is a related party, with whom the
Company has no employment relationship. The RSUs will vest over 4 years from the date of the grant - 25% each year.
In
October 2025, the Company granted 2,000 restricted stock units of the Company to two directors, with whom the Company has no employment
relationships. The restricted stock units will vest over 6 months from the date of the grant – 20% at the grant date and the remaining
80% will vest over the remaining 5 months, 16% each month.
In
November 2025, the Company granted 48,077 restricted stock units of the Company to an officer who is a related party, with whom the Company
has no employment relationship. The restricted stock units will vest over 1 year from the date of the grant.
In
November 2025, the Company granted 169,231 restricted stock units of the Company, to four directors, with whom the Company has no employment
relationships. The restricted stock units will vest over 1 year from the date of the grant.
In
April 2026, the Company granted 40,000 restricted stock units of the Company, to an officer who is a related party. The restricted stock
units will vest over 4 year from the date of the grant – 25% after one year from the date of the grant and the remaining 75% will
vest over the remaining 3 years, 2.1% each month.
The
cost of RSUs granted is determined by using the fair market value of the Company’s common stock on the date of grant.
The
following table summarizes the RSUs activity under the 2015 Plan as of June 30, 2026:
SCHEDULE
OF RESTRICTED STOCK UNIT ACTIVITY
| | |
units | | |
Weighted
average grant date fair value | |
| Outstanding at beginning of year | |
| 1,228,328 | | |
| 37.00 | |
| Granted | |
| 40,000 | | |
| 6.34 | |
| Vested (*) | |
| (2,000 | ) | |
| 39.80 | |
| Forfeited | |
| - | | |
| - | |
| Outstanding at end of period | |
| 1,266,328 | | |
| 36.03 | |
As
of June 30, 2026, there was unrecognized compensation cost related to unvested equity classified RSUs of $25,175 thousand which is expected
to be recognized as an expense on a straight-line basis over a weighted-average remaining vesting period of 3.16 years.
The
table below presents the expense recognized in the financial statements of the Company with respect to share-based payment:
ZOOZ
STRATEGY LTD
NOTES
TO THE FINANCIAL STATEMENTS (continued)
(Unaudited)
SCHEDULE
OF EXPENSE RECOGNIZED IN CONSOLIDATED FINANCIAL STATEMENTS
| | |
Six
months ended June 30 | |
| | |
2026 | | |
2025 | |
| | |
U.S.
dollars in thousands | |
| Equity classified awards: | |
| | | |
| | |
| Cost of revenue | |
| - | | |
| - | |
| Research and development expenses | |
| 1 | | |
| 6 | |
| Sales and marketing expenses | |
| - | | |
| 10 | |
| General and Administrative
expenses | |
| 13,773 | | |
| 43 | |
| | |
| 13,774 | | |
| 59 | |
NOTE
9 - RELATED PARTIES TRANSACTIONS:
SCHEDULE
OF RELATED PARTIES TRANSACTIONS
| | |
2026 | | |
2025 | |
| | |
Six
months ended June 30 | |
| | |
2026 | | |
2025 | |
| | |
U.S.
dollars in thousands | |
| Transactions with Related
Parties: | |
| | | |
| | |
Advisory
fees: | |
| | | |
| | |
| Digital assets
advisory fees (1) | |
| 194 | | |
| - | |
| Finance expenses: | |
| | | |
| | |
| Interest expense related
to Promissory note | |
| - | | |
| 80 | |
| Share-based compensation: | |
| | | |
| | |
| Research and development
income, net | |
| - | | |
| - | |
| General and administrative
expenses (2) | |
| 12,890 | | |
| 42 | |
| Share-based compensation | |
| 12,890 | | |
| 42 | |
During
the year ended December 31, 2025, the Company granted 672,682 RSUs to the New CEO.
The
fair value of the RSUs that were granted during the year ended December 31, 2025, is $28,791 thousand, which is expected to be recognized
over 4 years vesting period.
ZOOZ
STRATEGY LTD
NOTES
TO THE FINANCIAL STATEMENTS (continued)
(Unaudited)
NOTE
10 – SEGMENT INFORMATION
The
Company has one reportable operating segment, the “Flywheel,” which is engaged in developing and marketing Flywheel-based
power boosting and power management solutions. The “Corporate & Other” category presented in the following tables is
not considered an operating segment. It consists primarily of costs and expenses related to executing the Company’s bitcoin strategy
and includes the unrealized loss on digital assets and other third-party costs associated with the Company’s bitcoin holdings.
The
Company’s chief operating decision maker (“CODM”) is the Company’s Chief Executive Officer, who manages the entity
on a consolidated basis. The CODM uses “net loss” to assess operating results of the flywheel business by comparing actual
to budgeted results on a quarterly basis.
On
July 31, 2025, the Company appointed a new Chief Executive Officer, resulting in a change in the Company’s CODM. As a result, the
segment information regularly provided to the CODM changed, which also resulted in changes in the identification of significant segment
expenses. Accordingly, the Company recast the corresponding segment information for prior periods to conform to the current-year presentation.
The
following tables present the Company’s revenues and significant expenses regularly provided to the CODM, reconciled to net loss
for the period presented. Total segment assets provided to the CODM are also disclosed in the tables below for the period presented.
SCHEDULE
OF SEGMENT INFORMATION
| | |
Flywheel | | |
Corporate
& Other | | |
Total | |
| | |
Six
months ended June 30, 2026 | |
| | |
Flywheel | | |
Corporate
& Other | | |
Total | |
| | |
U.S.
dollars in thousands | |
| | |
| | |
| | |
| |
| Total revenues | |
| | | |
| | | |
| | |
| Significant segment expenses | |
| | | |
| | | |
| | |
| Inventory write-off (1) | |
| - | | |
| - | | |
| - | |
| Research and
development payroll(1) | |
| 530 | | |
| - | | |
| 530 | |
| Research and development
projects(1) | |
| 36 | | |
| - | | |
| 36 | |
| Operating lease and maintenance(1) | |
| 286 | | |
| - | | |
| 286 | |
| Professional Services(1) | |
| - | | |
| 930 | | |
| 930 | |
| Directors Insurance(1) | |
| - | | |
| 279 | | |
| 279 | |
| Investors relations expenses(1) | |
| - | | |
| 42 | | |
| 42 | |
| Share-based compensation
expense(1) | |
| 1 | | |
| 13,773 | | |
| 13,774 | |
| Unrealized loss on digital
asset(1) | |
| - | | |
| 30,328 | | |
| 30,328 | |
| Digital asset custody and
sponsor fees(1) | |
| - | | |
| 261 | | |
| 261 | |
| Other segment items (1) | |
| 427 | | |
| (38 | ) | |
| 389 | |
| Net loss | |
| 1,280 | | |
| 45,575 | | |
| 46,855 | |
| Total assets, as of June 30, 2026 (2) | |
| 2,698 | | |
| 84,730 | | |
| 87,428 | |
| | |
Flywheel | | |
Corporate
& Other | | |
Total | |
| | |
Six
months ended June 30, 2025 | |
| | |
Flywheel | | |
Corporate
& Other | | |
Total | |
| | |
U.S.
dollars in thousands | |
| Total revenues | |
| 247 | | |
| - | | |
| 247 | |
| Significant segment expenses | |
| | | |
| | | |
| | |
| Inventory write-off(1) | |
| 1,568 | | |
| - | | |
| 1,568 | |
| Research and development
payroll(1) | |
| 1,631 | | |
| - | | |
| 1,631 | |
| Research and development
projects(1) | |
| 245 | | |
| - | | |
| 245 | |
| Operating lease and maintenance(1) | |
| 328 | | |
| - | | |
| 328 | |
| Professional Services(1) | |
| - | | |
| 949 | | |
| 949 | |
| Directors Insurance(1) | |
| - | | |
| 316 | | |
| 316 | |
| Share-based compensation
expense(1) | |
| 53 | | |
| 6 | | |
| 59 | |
| Other segment items (1) | |
| 2,034 | | |
| 162 | | |
| 2,196 | |
| Net loss | |
| 5,612 | | |
| 1,433 | | |
| 7,045 | |
| Total assets, as of June 30, 2025 (2) | |
| 6,106 | | |
| 445 | | |
| 6,551 | |
NOTE
11 – LOSS PER SHARE
For
the period of six months ended June 30, 2026, the Company had 1,268,328 unvested RSUs, 21,195 options, 2,588,230 warrants and 200,000
earnout shares rights. For the period of six months ended June 30, 2025, the Company had 44,031 options 302,685 warrants and 200,000
earnout shares rights. These securities were not considered when calculating diluted loss per share since their effect is anti-dilutive.
NOTE
12 – SUBSEQUENT EVENTS
As
of August 23, 2026, the Company held approximately 1,047 bitcoins with an aggregate fair market value of $80.8 million (based on the
market price of $77,180 per bitcoin as reported on the Coinbase exchange as of August 23, 2026).
Exhibit 99.2
MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND
RESULTS OF OPERATIONS
The
following discussion and analysis of our financial condition and results of operations provides information that we believe to be relevant
to an assessment and understanding of our results of operations and financial condition for the periods described. This discussion should
be read in conjunction with our condensed consolidated interim financial statements and the notes thereto which are included in this
Report of Foreign Private Issuer on Form 6-K. In addition, this information should also be read in conjunction with the information contained
in the Company’s Annual Report on Form 20-F for the year ended December 31, 2025, filed with the Securities and Exchange Commission
(the “SEC”) on March 27, 2026 (the “2025 Annual Report”), including the audited consolidated annual
financial statements as of and for the year ended December 31, 2025, and the accompanying notes included therein.
As
a result of many factors, including those factors set forth in the section titled “Forward-Looking Statements,” as well as
the risk factors included in our 2025 Annual Report, ZOOZ’s actual results could differ materially from the results described in
or implied by the forward-looking statements contained in the following discussion and analysis. Throughout this section, unless otherwise
noted or the context requires otherwise, “we,” “us,” “our,” “ZOOZ” and the “Company”
refer to ZOOZ Strategy Ltd. and its consolidated subsidiary, “Keyarch” refers to Keyarch Acquisition Corporation, “TASE”
refers to the Tel Aviv Stock Exchange, “Yorkville” refers to Yorkville Advisors Global, LP, “Initial Private Placement”
refers to the private placement consummated on July 31, 2025 pursuant to the Initial Purchase Agreement between the Company and the investors
detailed therein, dated July 29, 2025, “Subsequent Private Placement” refers to the private placement consummated on September
26, 2025 pursuant to the Subsequent Purchase Agreement between the Company and the investors detailed therein, dated July 29, 2025 (and
together with the Initial Private Placement, the “Private Placement”), “Ordinary Warrants” refers to the warrants
to acquire our ordinary shares issued in the Initial Private Placement, “Subsequent Pre-Funded Warrants” refers to the pre-funded
warrants issued in the Subsequent Private Placement, “Sponsor” refers to Forest Hill 18, LP, “Sponsor Warrants”
refers to the warrants issued to the Sponsor pursuant to the Sponsor Support Agreement in connection with the Private Placement, “Sponsor
Pre-Funded Warrants” refers to the pre-funded warrants issued to the Sponsor, and “Chardan Ordinary Warrants” refers
to the warrants issued to Chardan Capital Markets LLC (“Chardan”) as placement agent fee in connection with the Private
Placement. With respect to monetary amounts, “dollars” and “$” refer to U.S. dollars, and “NIS” refers
to New Israeli shekels.
Certain
figures, including interest rates and other percentages included in this section, have been rounded for ease of presentation. Percentage
figures included in this section have not in all cases been calculated on the basis of such rounded figures but on the basis of such
amounts prior to rounding. For this reason, percentage amounts in this section may vary slightly from those obtained by performing the
same calculations using the figures in ZOOZ’s condensed consolidated interim financial statements or in the associated text. Certain
other amounts that appear in this section may similarly not sum due to rounding.
Company
Overview
On
April 4, 2024, Keyarch Acquisition Corporation and the Company consummated their previously announced Business Combination pursuant to
that certain Business Combination Agreement (the “Business Combination”), pursuant to which Keyarch became a direct,
wholly-owned subsidiary of ZOOZ. In connection with the closing of the Business Combination, our ordinary shares and public warrants
began trading on the Nasdaq Capital Market LLC (“Nasdaq”) under the ticker symbols “ZOOZ” and “ZOOZW”,
respectively, on April 5, 2024.
On
July 29, 2025, the Company entered into securities purchase agreements with certain institutional and accredited investors for the Private
Placement consisting of ordinary shares, pre-funded warrants, and warrants. Following the entry into the Private Placement, the Company
adopted bitcoin as its primary treasury reserve asset, subject to market conditions and its anticipated cash needs. Under this strategy,
the Company may acquire and hold bitcoin using cash flows in excess of working capital requirements and subject to market conditions,
raise capital through equity or debt offerings with proceeds used to purchase bitcoin.
The
Company currently operates primarily as a bitcoin treasury company, and to a lesser extent, continues to operate in developing, producing,
marketing, and selling systems that manage and optimize power delivery to clusters of ultra-fast EV chargers (the “Legacy Business”)
and seeks to commercialize its EV ultra-fast charging infrastructure and related technology, and it is exploring strategic alternatives
to capitalize on its patented flywheel technology.
Our
Bitcoin Strategy
Our
bitcoin strategy generally involves from time to time and subject to market conditions, (i) engaging in capital raising transactions
(and, where we may deem appropriate, other financing transactions, including debt financing) with the objective of using the proceeds
to purchase bitcoin and (ii) acquiring bitcoin with the portion of our liquid assets that exceeds our working capital requirements. We
intend to fund further bitcoin acquisitions primarily through issuances of our ordinary shares.
We
view our bitcoin holdings as long-term assets and expect to continue to accumulate bitcoin. We have not set any specific target for the
amount of bitcoin we seek to hold, and we will continue to monitor market conditions in determining whether to engage in additional financings
to purchase additional bitcoin. This strategy also contemplates that we may (i) periodically sell bitcoin for general corporate purposes,
or to generate tax benefits in accordance with applicable law, (ii) enter into additional capital raising transactions that are collateralized
by our bitcoin holdings, and (iii) pursue strategies to create income streams or otherwise generate funds using our bitcoin holdings.
Under
our bitcoin treasury reserve strategy, our treasury reserve assets consist of:
●
cash and cash equivalents and short-term investments (“Cash Assets”) held by us that exceed working capital
requirements; and
●
bitcoin held by us, with bitcoin serving as the primary treasury reserve asset on an ongoing basis, subject to market conditions and
anticipated needs of the business for Cash Assets.
During
the six months ended June 30, 2026, we did not purchase any bitcoin. During the second half of 2025, we used proceeds from the Private
Placement to purchase bitcoin, as detailed below.
As
of both June 30, 2026, and December 31, 2025, we held approximately 1,047 bitcoins.
The
following table presents our bitcoin holdings, including additional information related to our bitcoin purchases and unrealized losses
on digital assets as of December 31, 2025, and June 30, 2026:
| | |
Digital Asset Original Cost Basis (in thousands) | | |
Unrealized Loss on Digital Assets Recognized During the Period (in thousands) | | |
Digital Asset Carrying Value (in thousands) | | |
Approximate Number of Bitcoins Held | | |
Approximate Average Purchase Price Per Bitcoin (in thousands) | |
| Balance at December 31, 2025 | |
$ | 121,935 | | |
$ | 30,307 | | |
$ | 91,628 | | |
| 1,047 | | |
| 116 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
| Balance at June 30, 2026 | |
$ | 121,935 | | |
$ | 30,328 | | |
$ | 61,300 | | |
| 1,047 | | |
| 116 | |
We
recognized an unrealized loss on digital assets of approximately $30,328 thousand for the six-month period ended June 30, 2026, due to
a decrease in the fair value of our bitcoin holdings during the six months ended June 30, 2026, compared to an unrealized loss of approximately
$30,307 thousand for the year ended December 31, 2025.
Due
to the volatility of bitcoin, and our substantial holdings of bitcoin, we expect changes in the fair value of bitcoin to materially impact
our results.
The
following table shows the approximate number of bitcoins held as of June 30, 2026, and December 31, 2025, as well as market value calculations
of our bitcoin holdings based on the lowest, highest, and ending market prices of one bitcoin for each of the periods presented. For
2025, the period presented commences on the date of our first bitcoin purchase, as further defined below:
| | |
Approximate Number of Bitcoins Held at End of Period | | |
Lowest Market Price Per Bitcoin During Period (a) | | |
Market Value of Bitcoin Held at End of Period Using Lowest Market Price (in thousands) (b) | | |
Highest Market Price Per Bitcoin During Period (c) | | |
Market Value of Bitcoin Held at End of Period Using Highest Market Price (in thousands) (d) | | |
Market Price Per Bitcoin at End of Period (e) | | |
Market Value of Bitcoin Held at End of Period Using Ending Market Price (in thousands) (f) | |
| December 31, 2025 | |
| 1,047 | | |
| 84,414 | | |
| 88,378 | | |
| 125,528 | | |
| 131,422 | | |
| 87,519 | | |
| 91,628 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| June 30, 2026 | |
| 1,047 | | |
| 58,551 | | |
| 61,300 | | |
| 97,332 | | |
| 101,907 | | |
| 58,551 | | |
| 61,300 | |
| |
(a) |
The
“Lowest Market Price Per Bitcoin During Period” represents the lowest market price for one bitcoin reported on the Coinbase
exchange during the presented period, without regard to when we purchased any of our bitcoin. |
| |
|
|
| |
(b) |
The
“Market Value of Bitcoin Held at End of Period Using Lowest Market Price” represents a mathematical calculation consisting
of the lowest market price for one bitcoin reported on the Coinbase exchange during the presented period, multiplied by the number
of bitcoins held by us at the end of such period. |
| |
|
|
| |
(c) |
The
“Highest Market Price Per Bitcoin During Period” represents the highest market price for one bitcoin reported on the
Coinbase exchange during the presented period, without regard to when we purchased any of our bitcoin. |
| |
|
|
| |
(d) |
The
“Market Value of Bitcoin Held at End of Period Using Highest Market Price” represents a mathematical calculation consisting
of the highest market price for one bitcoin reported on the Coinbase exchange during the presented period, multiplied by the number
of bitcoins held by us at the end of such period. |
| |
|
|
| |
(e) |
The
“Market Price Per Bitcoin at End of Period” represents the market price of one bitcoin per a statement issued by BitGo,
our custodian, as of 23:59 p.m. Eastern Time on the last day of the presented period. |
| |
(f) |
The
“Market Value of Bitcoin Held at End of Period Using Ending Market Price” represents a mathematical calculation consisting
of the market price of one bitcoin per a statement issued by BitGo, our custodian, as of 23:59 p.m. Eastern Time on the last day
of the presented period multiplied by the number of bitcoins held by us at the end of such period. |
The
bitcoin market and the spot price of bitcoin may be subject to fraud and manipulation; accordingly, the market value amounts reported
above may not accurately represent fair market value. Moreover, (i) the bitcoin market historically has been characterized by significant
price volatility, limited liquidity and trading volumes compared to sovereign currency markets, relative anonymity, a developing regulatory
landscape, susceptibility to market abuse and manipulation, compliance and internal control failures at exchanges, and various other
risks inherent in its electronic and decentralized nature and (ii) we may not be able to sell our bitcoin at the market value amounts
indicated above, or at all.
As
of August 24, 2026, the Company has not purchased additional bitcoin other than as detailed in the table above. As of August 23, 2026,
at 23:59 p.m. Eastern Time, the market price of one bitcoin as reported on the Coinbase exchange was $77,180.
Recent
Developments
On
January 15, 2026, each of Dr. Samer Haj-Yehia and Mr. Fang Zheng announced to the Company their intentions to step down from service
on the Board of Directors (the “Board”) effective as of January 20, 2026, due to personal reasons not associated with
the Company. On January 16, 2026, the Company’s Board agreed to reduce the size of its board from eight to six members.
On
December 16, 2025, the Company received a written notice from Nasdaq notifying the Company that it was not in compliance with the minimum
bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). The notice was issued because the closing bid price of the Company’s
ordinary shares had been below $1.00 per share for 30 consecutive business days. In accordance with the applicable Nasdaq Listing Rules,
the Company was provided with a period of 180 calendar days, or until June 15, 2026, to regain compliance.
On
June 15, 2026, the Company received a written letter from Nasdaq notifying the Company that
Nasdaq has now determined that, for the last 10 consecutive business days from June 1, 2026, to June 12, 2026, the closing bid price
of the Company’s ordinary shares was $1.00 per share or greater. Accordingly, Nasdaq has formally notified the Company that it
has regained compliance with Nasdaq Listing Rule 5550(a)(2), and that the prior bid price deficiency matter is closed.
On
May 11, 2026, following approval by the Company’s Board of Directors, the shareholders of the Company approved a reverse share
split of the Company’s ordinary shares at a ratio ranging from one (1) Ordinary Share for every ten (10) ordinary shares to one
(1) ordinary share for every twenty (20) ordinary shares (the “Split Ratio Range”), with the specific ratio to be
determined by the Board in its sole and absolute discretion, together with a corresponding amendment to the Company’s Articles
of Association to give effect to the resulting changes in the Company’s registered share capital and the par value of the ordinary
shares arising from the reverse split (the “May 2026 Shareholders Meeting”).
Following
the May 2026 Shareholders Meeting, the Board duly approved a reverse split ratio of one (1) ordinary share for every twenty (20) ordinary
shares (the “Reverse Share Split”), and the Company’s Articles of Association, as in effect as of the effective date
of such change, were amended accordingly to reflect such Reverse Share Split.
On
June 1, 2026, the Company announced that the Reverse Share Split, became effective and the ordinary shares began trading on a reverse
split-adjusted basis under the Company’s existing trading symbol “ZOOZ” as of the opening of trading on each of the
Nasdaq Capital Market and on the Tel Aviv Stock Exchange.
The
Company previously entered into a sales agreement (“Sales Agreement”) with Chardan dated July 29, 2025, relating to
the sale of its ordinary shares. In accordance with the terms of the Sales Agreement, and pursuant to the prospectus supplement filed
with the SEC on July 29, 2025, the Company registered the offer and sale of ordinary shares having an aggregate offering price of up
to $10,950,000 from time to time through Chardan, acting as its sales agent. On September 30, 2025, the Company entered into an amended
and restated sales agreement (the “A&R Sales Agreement”) with Chardan and Jett Capital Advisors, LLC (“Jett
Capital”, and together with Chardan, the “Agents”), relating to the sale of its ordinary shares. In accordance
with the terms of the A&R Sales Agreement, and pursuant to the prospectus supplement filed with the SEC on September 30, 2025, the
Company registered the offer and sale of ordinary shares having an aggregate offering price of up to $1,000,000,000 from time to time
through the Agents, acting as its sales agents.
During
the six-month period ended June 30, 2026, the Company did not sell any ordinary shares under the A&R Sales Agreement.
As
of June 30, 2026, the Company sold a total of 57,141 ordinary shares at an average price of $69.8 per ordinary share pursuant to the
Sales Agreement and the A&R Sales Agreement, for total gross proceeds of $3.9 million.
| ● | Share Repurchase
Program |
On
November 3, 2025, the Company announced that the Board has approved the adoption of a share repurchase program to acquire up to $50 million
of outstanding ordinary shares, subject to meeting applicable regulatory requirements (the “Repurchase Program”).
The Repurchase Program is for a 12-month period and allows the Company to repurchase ordinary shares from time to time using a variety
of methods, including open market purchases, negotiated transactions or otherwise, all subject to applicable law.
During
the six-month period ended June 30, 2026, the Company repurchased an aggregate of 91,551 ordinary shares under the Repurchase Program,
at a weighted average purchase price of $9.42 for aggregate consideration of $881,268. As of December 31, 2025, the Company did not repurchase
any ordinary shares under the Repurchase Program.
| ● |
Standby
Equity Purchase Agreement with Yorkville |
On
November 11, 2024, we entered into a Standby Equity Purchase Agreement with Yorkville (the “SEPA”), pursuant to which,
and subject to customary conditions, we have the right, but not the obligation, to sell and issue to Yorkville from time to time (each
such occurrence, an “Advance”) during the two-year period following the execution date of the SEPA, such amount of
the ordinary shares for an aggregate purchase price of up to $12,000,000 in accordance with the terms of the SEPA.
During
2025, the Company sold and issued to Yorkville a total of 19,727 ordinary shares pursuant to Advances provided to Yorkville for an aggregate
amount of $0.4 million, at a weighted average share price of $20.6 per share. During the six-month period ended June 30, 2026, the Company
did not sell or issue to Yorkville any ordinary shares pursuant to the SEPA.
Comparison
of the Six Months Ended June 30, 2026, to the Six Months Ended June 30, 2025
Results
of Operations
The
following table sets forth our results of operations data for the periods presented:
| | |
Six
months ended June 30, | |
| | |
2026 | | |
2025 | |
| | |
US dollars in thousands (unaudited) | |
| Revenues | |
| - | | |
| 247 | |
| Cost of revenue | |
| - | | |
| 1,792 | |
| Gross loss | |
| - | | |
| (1,545 | ) |
| Research and development, net | |
| 896 | | |
| 2,352 | |
| Sales and marketing | |
| 45 | | |
| 998 | |
| General and administrative | |
| 15,612 | | |
| 1,950 | |
| Unrealized loss on digital assets | |
| 30,328 | | |
| - | |
| Operating loss | |
| (46,881 | ) | |
| (6,845 | ) |
| Finance income (expenses), net | |
| 26 | | |
| (200 | ) |
| Net loss | |
| (46,855 | ) | |
| (7,045 | ) |
| Net loss per ordinary share attributable to shareholders - basic and diluted | |
| (4.93 | ) | |
| (12.2 | ) |
| Weighted average ordinary shares outstanding – basic and diluted in thousands | |
| 9,498 | | |
| 577 | |
As
a result of the net loss of $46,855 thousand for the six months ended June 30, 2026, the Company’s shareholders’ equity amounted
to $85,238 thousand.
Cost
of Revenue
| | |
Six
months ended June 30, | |
| | |
2026 | | |
2025 | |
| | |
US dollars in thousands (unaudited) | |
| Cost of revenue | |
| - | | |
| 1,792 | |
Cost
of revenue consisted of (a) cost of systems that were sold and recognized for revenues, (b) anticipated net realizable value of disposition
of existing inventory assets, (c) provision for warranty, and (d) provision for royalties.
For
the six months ended June 30, 2026, the Company recorded no cost of revenue. For the six months ended June 30, 2025, cost of revenue
was $1,792 thousand and included inventory write-offs of $1,227 thousand and raw material write-offs of $341 thousand. The raw material
write-off reflected the Company’s expectation that no additional systems would be produced in the foreseeable future.
Operating
Expenses
| | |
Six
months ended June 30, | |
| | |
2026 | | |
2025 | |
| | |
US dollars in thousands (unaudited) | |
| Research and development, net | |
| 896 | | |
| 2,352 | |
| Sales and marketing, net | |
| 45 | | |
| 998 | |
| General and administrative | |
| 15,612 | | |
| 1,950 | |
| Unrealized loss on digital assets | |
| 30,328 | | |
| - | |
| Total operating expenses | |
| 46,881 | | |
| 5,300 | |
Operating
expenses for the six months ended June 30, 2026, increased to $46.9 million from $5.3 million in the comparable period of 2025, mainly
due to the unrealized loss on digital assets and higher general and administrative expenses, partially offset by lower research and development
and sales and marketing expenses.
Research
and Development Expenses, Net
For
the six months ended June 30, 2026, research and development expenses, net, decreased by $1,456 thousand, from $2,352 thousand for the
six months ended June 30, 2025, to $896 thousand for the six months ended June 30, 2026. The decrease was mainly attributable to workforce
reductions and the significant reduction in the Company’s research and development activities.
Sales
and Marketing Expenses
Sales
and marketing expenses decreased by $953 thousand, from $998 thousand for the six months ended June 30, 2025, to $45 thousand for the
six months ended June 30, 2026. The decrease was primarily attributable to the significant reduction in the Company’s legacy business
activities, including workforce reductions and the discontinuation of marketing activities.
General
and Administrative Expenses
General
and administrative expenses increased by $13,662 thousand, from $1,950 thousand for the six months ended June 30, 2025, to $15,612 thousand
for the six months ended June 30, 2026. The increase in the six months ended June 30, 2026, compared to the comparable period of 2025,
is primarily attributable to share-based compensation of approximately $13,773 thousand related to RSU grants to the CEO, CFO, the Chairman
of the Board, and the Company’s directors.
Finance
income (expenses), net
Finance
income (expenses), net improved by approximately $226 thousand, from $200 thousand of finance expenses for the six months ended June
30, 2025, to $26 thousand of finance income for the six months ended June 30, 2026. The change was primarily due to interest expenses
accrued on the EBC and Keyarch Global Notes, in the comparable period of 2025, which were fully repaid in September 2025, as well as
interest income earned on deposits during the first half of 2026.
Liquidity
and Capital Resources
Overview
ZOOZ
has historically funded its operations primarily from private placements of its equity securities and public offerings of its securities
following its initial public offering on the Tel Aviv Stock Exchange, as well as the Business Combination and Merger between ZOOZ, Keyarch
Acquisition Corporation and the other parties thereto, which was consummated on April 4, 2024, from the SEPA, from ATM programs and from
the Private Placement.
As
of June 30, 2026, the Company’s principal sources of funding include: (i) net proceeds of approximately $52 million from its initial
public offering on the TASE in 2021 and a follow-on public offering in 2022, together with related private placements; (ii) approximately
$10 million received in connection with the Business Combination and Merger; (iii) approximately $153 million from the Private Placement;
(iv) approximately $3.8 million raised under its ATM programs; and (v) approximately $0.4 million received under the SEPA.
As
of June 30, 2026, the Company had $23,271 thousand in cash and cash equivalents.
In
addition, as of June 30, 2026, the Company had the following warrants to purchase ordinary shares issued and outstanding:
| |
● |
288,862
public warrants (listed on the Nasdaq under the symbol “ZOOZW”) to purchase up to the same number of ordinary shares,
with an exercise price of $230 per warrant; |
| |
|
|
| |
● |
12,263
private warrants to purchase up to the same number of ordinary shares, with an exercise price of $230 per warrant; |
| |
|
|
| |
● |
2,018,045
sponsor warrants issued in connection with the Private Placement, each to purchase one ordinary share; |
| |
|
|
| |
● |
900,000
Subsequent Pre-Funded Warrants to purchase up to the same number of ZOOZ ordinary shares, with an exercise price of $1 per warrant; |
| |
|
|
| |
● |
250,000
Ordinary Warrants to purchase up to the same number of ZOOZ ordinary shares, issued in the Initial Private Placement, with an exercise
price of $3.06 per warrant; |
| |
|
|
| |
● |
250,000
pre-funded warrants to purchase up to the same number of ZOOZ ordinary shares, issued to Chardan pursuant to the Engagement Letter
(the “Chardan Pre-Funded Warrants”), with an exercise price of $1 per warrant; |
| |
|
|
| |
● |
17,500
Chardan Ordinary Warrants to purchase up to the same number of ZOOZ ordinary shares, having
the same purchase price as the Ordinary Warrants detailed above; and
|
| |
|
|
| |
● |
326,297
Sponsor Pre-Funded Warrants to purchase the same number of ZOOZ ordinary shares, with an
exercise price of $1 per warrant.
|
Significant
Accounting Policies
The
preparation of financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, obligations,
income and expenses during the reporting periods. A comprehensive discussion of our critical accounting estimates is included under Note
2 to the financial statements included in the Company’s 2025 Annual Report.
Forward-Looking
Statements
This
Report of Foreign Private Issuer on Form 6-K contains “forward-looking statements” within the meaning of the “safe
harbor” provisions of the Private Securities Litigation Reform Act of 1995. All statements in this report other than statements
of historical facts are “forward-looking statements.” These statements may be identified by words such as “aims,”
“anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,”
“goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,”
“will” and variations of these words or similar expressions that are intended to identify forward-looking statements, although
not all forward-looking statements contain these words. Forward-looking statements in this Report of Foreign Private Issuer on Form 6-K
include statements regarding the Company’s bitcoin treasury strategy and the implementation thereof, the timing and scope of any
sale and issuance of our ordinary shares (if any) pursuant to the A&R Sales Agreement or SEPA, the timing and scope of any share
repurchases pursuant to the Repurchase Program (if any), the potential value of our bitcoin strategy and any share sales or purchases
we may make pursuant to the A&R Sales Agreement, SEPA or the Repurchase Program to shareholders. These forward-looking statements
are based on the Company’s expectations and assumptions as of the date of this report. Each of these forward-looking statements
involves risks and uncertainties that could cause the Company’s future results or performance to differ materially from those expressed
or implied by the forward-looking statements. Many factors may cause differences between current expectations and actual results, including:
the impacts of macroeconomic conditions, heightened inflation and uncertain credit and financial markets, on the Company’s business
and financial position; changes in expected or existing competition; changes in the regulatory environment; unexpected litigation or
other disputes; risks related to the bitcoin treasury strategy; the risk that the Company’s share price may be highly correlated
to the price of the bitcoin that it holds; risks relating to significant legal, commercial, regulatory, and technical uncertainty regarding
digital assets generally; risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; general market, political,
and economic conditions in the countries in which the Company operates, including Israel; and the effect of the evolving nature of the
recent war in Israel. Other factors that may cause the Company’s actual results to differ from those expressed or implied in the
forward-looking statements in this Report of Foreign Private Issuer on Form 6-K are identified under the heading “Risk Factors”
in the 2025 Annual Report, and in other filings that the Company makes and will make with the SEC in the future. The Company expressly
disclaims any obligation to update any forward-looking statements contained herein, whether as a result of any new information, future
events, changed circumstances or otherwise, except as otherwise required by law.